Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 5
1  |  2  |  3  |  4  |  5

Scientific Advancements
Friday, May 18, 2018   (0 Comments - view/add)
Prevacus Partners with BrainScope for Upcoming Drug Study on Concussion »
Prevacus Partners with BrainScope for Upcoming Drug Study on Concussion TALLAHASSEE, Fla. , May 18, 2018 /PRNewsw...
Thursday, April 26, 2018   (0 Comments - view/add)
Human-on-a-chip Company Hesperos Licenses First Functional Stem-Cell Derived Neuromuscular Junction »
Human-on-a-chip Company Hesperos Licenses First Functional Stem-Cell Derived Neuromuscular Junction Model Innova...
Thursday, April 19, 2018   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK »
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK Antibody Positive Mya...
Wednesday, April 18, 2018   (0 Comments - view/add)
AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked R »
AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa...
Tuesday, April 10, 2018   (0 Comments - view/add)
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therap »
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients with X-l...
Thursday, March 29, 2018   (0 Comments - view/add)
CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappso »
CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Trea...
Thursday, March 29, 2018   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of »
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthe...
Wednesday, March 28, 2018   (0 Comments - view/add)
Data Showcasing Strength of RTI’s SImmetry® System in Sacroiliac Joint Fusion Published in The Spine »
Data Showcasing Strength of RTI’s SImmetry® System in Sacroiliac Joint Fusion Published in The Spine Journal S...
Friday, March 23, 2018   (0 Comments - view/add)
Oragenics Completes Enrollment for the Interim Analysis Cohort in Its Phase 2 Clinical Trial of AG01 »
Oragenics Completes Enrollment for the Interim Analysis Cohort in Its Phase 2 Clinical Trial of AG013 for Oral Mucositis...
Tuesday, March 20, 2018   (0 Comments - view/add)
KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolesc »
KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolescents With ADHD &...
Monday, March 19, 2018   (0 Comments - view/add)
Oragenics, Inc. Announces Peer Reviewed Publication Examining Efficacy of Mutacin 1140 Lantibiotic V »
Oragenics, Inc. Announces Peer Reviewed Publication Examining Efficacy of Mutacin 1140 Lantibiotic Variants against Clost...
Friday, March 16, 2018   (0 Comments - view/add)
Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic »
Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic   TAMPA, Fla., March 16, 20...
Thursday, March 15, 2018   (0 Comments - view/add)
TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical »
TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical Cancer Research &n...
Wednesday, March 14, 2018   (0 Comments - view/add)
Jupiter Orphan Therapeutics Announces Submission of Investigational New Drug Application (IND) For T »
Jupiter Orphan Therapeutics Announces Submission of Investigational New Drug Application (IND) For Treatment Of Mucopolysa...
Monday, March 12, 2018   (0 Comments - view/add)
Publication in Blood Advances® Reports that the Combination of Cantex Pharmaceuticals' CX-01 with Ch »
Publication in Blood Advances® Reports that the Combination of Cantex Pharmaceuticals' CX-01 with Chemotherapy for the Tre...
Monday, March 12, 2018   (0 Comments - view/add)
CTD Holdings Announces FDA Authorization to Proceed with Single Patient IND for Use of Trappsol(R) C »
CTD Holdings Announces FDA Authorization to Proceed with Single Patient IND for Use of Trappsol(R) Cyclo(TM) to Treat Alzh...
Thursday, March 8, 2018   (0 Comments - view/add)
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee »
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for...
Monday, March 5, 2018   (0 Comments - view/add)
Fort Walton Beach Medical Center - First Hospital in the Area to Implant the World’s Smallest and Le »
FOR IMMEDIATE RELEASE   Media Contact: Fort Walton Beach Medical Center      &...
Tuesday, February 27, 2018   (0 Comments - view/add)
First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition »
First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of Groundbrea...
Tuesday, February 27, 2018   (0 Comments - view/add)
Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe P »
Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe Pharma Corporation To P...
Friday, February 23, 2018   (0 Comments - view/add)
KemPharm Announces FDA Approval of Apadaz(TM) (benzhydrocodone and acetaminophen) for the Short-Term »
KemPharm Announces FDA Approval of Apadaz™ (benzhydrocodone and acetaminophen) for the Short-Term Management of Acute Pain...
Wednesday, February 14, 2018   (0 Comments - view/add)
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults »
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults New quick testing option...
Tuesday, February 13, 2018   (0 Comments - view/add)
Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraf »
Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry T...
Monday, February 12, 2018   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® »
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® Positive meeting with...
Monday, February 12, 2018   (0 Comments - view/add)
FDA Approves SYMDEKOTM (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic »
FDA Approves SYMDEKO TM (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in Peop...
Wednesday, February 7, 2018   (0 Comments - view/add)
Xcovery Announces Initiation of Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK »
Xcovery Announces Initiation of Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations...
Wednesday, February 7, 2018   (0 Comments - view/add)
Dyadic International, Inc. Announces Research and Development Collaboration To Produce An Active Ing »
Dyadic International, Inc. Announces Research and Development Collaboration To Produce An Active Ingredient in C1 02/07...
Wednesday, January 31, 2018   (0 Comments - view/add)
Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Tr »
Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophren...
Monday, January 29, 2018   (0 Comments - view/add)
CTD Holdings Initiates Research Program to Explore Cyclodextrin Therapy for Alzheimer's Disease »
CTD Holdings Initiates Research Program to Explore Cyclodextrin Therapy for Alzheimer's Disease ALACHUA, FL -- (Mark...
Wednesday, January 24, 2018   (0 Comments - view/add)
Published Data Show Successful 24-Month Sacroiliac Joint Fusion and Pain Reduction with the SImmetry »
Published Data Show Successful 24-Month Sacroiliac Joint Fusion and Pain Reduction with the SImmetry® System Stu...
Wednesday, January 24, 2018   (0 Comments - view/add)
FSU psychologist receives $2M NIH grant to test nonmedication treatment for ADHD »
FSU psychologist receives $2M NIH grant to test nonmedication treatment for ADHD By: Dave Heller | Published: Jan...
Monday, January 8, 2018   (0 Comments - view/add)
KemPharm Initiates Pivotal Efficacy Trial of KP415 »
KemPharm Initiates Pivotal Efficacy Trial of KP415   'Classroom-style' Pivotal Efficacy Trial of ADHD...
Wednesday, January 3, 2018   (0 Comments - view/add)
Area company Espero looks to hold trials for new drugs »
Shared from the 2018-01-03 The Florida Times-Union eEdition Area company Espero looks to hold trials for new drugs...
Wednesday, January 3, 2018   (0 Comments - view/add)
Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Tre »
Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloi...
Tuesday, December 12, 2017   (0 Comments - view/add)
TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negati »
TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negative Breast Cancer Funde...

Displaying page 1 of 5
1  |  2  |  3  |  4  |  5

About BioFlorida

BioFlorida represents nearly 6,000 establishments and research organizations in the biopharmaceutical, medical technology and bioagriculture sectors that collectively employ nearly 83,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

Email us for a regional Chapter sponsorship.

Connect